Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00156845 · ClinicalTrials.gov registry record · Phase 3

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography

A Phase 3 study, sponsored by Acusphere.

Completed
Registry status
Phase 3
Development phase
450
Enrollment target

NCT00156845: Completed Phase 3 study, sponsored by Acusphere.

NCT00156845 is a Phase 3 study that has completed, run by Acusphere. The registered enrollment target is 450 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00156845, a Phase 3 study, has completed, sponsored by Acusphere.

COMPLETED
Registry status
Phase 3
Development phase
450 participants
Enrollment target

Study Summary

This study was designed to evaluate the ability of AI-700-enhanced rest-stress echocardiography to detect coronary artery disease (CAD) in patients with suspected ischemic heart disease who are indicated for coronary angiography.

Interventions

  • PROCEDURE AI-700 contrast-enhanced echocardiography

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2003-12
Est. Completion 2006-06
Phase Phase 3
Acusphere

5 total trials

What the finished NCT00156845 record still lists

NCT00156845 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower).

The record links to 0 conditions, and to 1 intervention - of which AI-700 contrast-enhanced echocardiography is the first listed.

NCT00156845 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00156845 about?

NCT00156845 is a clinical study titled "Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography". This study was designed to evaluate the ability of AI-700-enhanced rest-stress echocardiography to detect coronary artery disease (CAD) in patients with suspected ischemic heart disease who are indicated for coronary angiography.

What is the current status of trial NCT00156845?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 450 participants. The study started on 2003-12. Estimated completion is 2006-06.

What interventions are being tested in trial NCT00156845?

The interventions under investigation include: AI-700 contrast-enhanced echocardiography (PROCEDURE).

Who is sponsoring clinical trial NCT00156845?

This trial is sponsored by Acusphere, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00156845's enrollment target sits among peer trials

450 837th of 2000 higher than 1,137 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00156845, the US trial registry maintained by the National Library of Medicine. NCT00156845 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.